Mizuho Securities Reiterates ContraFect (CFRX) a Buy with $9 Price Target Ahead of Upcoming DISRUPT Study Readout
Tweet Send to a Friend
Mizuho Securities analyst Vamil Divan reiterated a Buy rating and $9.00 price target on ContraFect Corp. (NASDAQ: CFRX), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
